Cell Therapy Catapult Limited

Cell Therapy Catapult Limited is an SME in London, United Kingdom that has taken part in 7 EU-funded projects since 2016, receiving €2.0M in EU funding.

EU funding received€2.0M
EU projects7
As coordinator0
Running now1
First EU project2016
Latest project2026
CountryUnited Kingdom
EU registration (PIC)949570346
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cell Therapy Catapult Limited's own share of each project, not the project's full budget.

  • Horizon 2020€1.7M · 5 projects
  • Horizon Europe€287k · 2 projects

Projects

7 EU-funded projects, newest first. Each links to the official record.

  • S.O.L.A.R.I.S.Partner

    A NEW DAWN IN NEXT-GENERATION CAR-T MANUFACTURING

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €287ktheir share
  • SMARTERAssociated partner

    Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process control

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • EuroGCTPartner

    European consortium for communicating gene- and cell-based therapy information.

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • RESTOREPartner

    RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €53ktheir share
  • RESHAPEPartner

    Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €1.0Mtheir share
  • AUTOSTEMPartner

    Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient”

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €300ktheir share
  • TETRAPartner

    Autologous Stem Cell Seeded Tissue Engineered Trachea

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €282ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • bioreactors
  • cells technologies
  • gene therapy
  • hepatology
  • immunotherapy
  • manufacturing engineering
  • melanoma
  • oncology
  • pharmaceutical drugs
  • remote sensing
  • sensors
  • spectroscopy
  • stem cells
  • surgical procedures

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime